CURE bleeding criteria

Bleeding Microchapters
Home
Patient Information
Overview
Classification
Bleeding Academic Research Consortium
TIMI bleeding criteria
GUSTO bleeding criteria
CURE bleeding criteria
ACUITY HORIZONS bleeding criteria
STEEPLE bleeding criteria
PLATO bleeding criteria
GRACE bleeding criteria
Causes
Treatment
Emergency Bleeding Control
Reversal of Anticoagulation and Antiplatelet in Active Bleed
Perioperative Bleeding
Anemia Management
Coagulation Monitoring
Coagulation Management
Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy Antiplatelet Agents Heparin Fondaparinux Vitamin K Antagonists New Oral Anticoagulants Comorbidities Involving Hemostatic Derangement
Specific Surgeries Cardiovascular Surgery Gynecological Bleeding Obstetric Bleeding Orthopedic/Neurosurgery Visceral/Transplant Surgery Pediatric Surgery
Congenital Bleeding Disorders von Willebrand Disease Platelet Defects Hemophilia A and B Factor VII Deficiency Rare Bleeding Disorders
CURE bleeding criteria On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of CURE bleeding criteria All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on CURE bleeding criteria
CDC on CURE bleeding criteria
CURE bleeding criteria in the news
Blogs on CURE bleeding criteria
Directions to Hospitals Treating Bleeding
Risk calculators and risk factors for CURE bleeding criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

CURE Clinical Trials:

[[The Clopidogrel In Unstable Angina To Prevent Recurrent Events Trial

Clopidogrel In Unstable Angina To Prevent Recurrent Ischemic Events

“

Major bleeding Life-threatening (fatal, intracranial, requiring surgical intervention, results in substantial hypotension requiring the use of intravenous inotropic agents) Hemoglobin decrease ≥5 g/dL or required ≥4 U of blood Other major bleeding Transfusion of 2–3 U, intraocular Minor Led to discontinuation of study drug

”